- Home
- TBPH vs MCBS Comparison
TBPH vs MCBS Comparison
Compare TBPH & MCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBPH
- MCBS
- Stock Information
- Founded
- TBPH 2013
- MCBS 2006
- Country
- TBPH United States
- MCBS United States
- Employees
- TBPH N/A
- MCBS N/A
- Industry
- TBPH Biotechnology: Pharmaceutical Preparations
- MCBS Major Banks
- Sector
- TBPH Health Care
- MCBS Finance
- Exchange
- TBPH Nasdaq
- MCBS Nasdaq
- Market Cap
- TBPH 699.0M
- MCBS 744.2M
- IPO Year
- TBPH N/A
- MCBS 2019
- Fundamental
- Price
- TBPH $13.95
- MCBS $29.49
- Analyst Decision
- TBPH Strong Buy
- MCBS Hold
- Analyst Count
- TBPH 3
- MCBS 1
- Target Price
- TBPH $21.33
- MCBS $34.00
- AVG Volume (30 Days)
- TBPH 602.7K
- MCBS 31.7K
- Earning Date
- TBPH 08-12-2025
- MCBS 10-17-2025
- Dividend Yield
- TBPH N/A
- MCBS 3.12%
- EPS Growth
- TBPH N/A
- MCBS 20.64
- EPS
- TBPH 0.26
- MCBS 2.57
- Revenue
- TBPH $77,205,000.00
- MCBS $145,158,000.00
- Revenue This Year
- TBPH $78.36
- MCBS $18.90
- Revenue Next Year
- TBPH N/A
- MCBS $30.18
- P/E Ratio
- TBPH $54.52
- MCBS $11.47
- Revenue Growth
- TBPH 24.49
- MCBS 14.81
- 52 Week Low
- TBPH $7.88
- MCBS $24.24
- 52 Week High
- TBPH $14.55
- MCBS $36.15
- Technical
- Relative Strength Index (RSI)
- TBPH 71.41
- MCBS 53.52
- Support Level
- TBPH $13.66
- MCBS $29.05
- Resistance Level
- TBPH $14.55
- MCBS $30.15
- Average True Range (ATR)
- TBPH 0.46
- MCBS 0.58
- MACD
- TBPH -0.02
- MCBS 0.05
- Stochastic Oscillator
- TBPH 56.20
- MCBS 61.50
About TBPH Theravance Biopharma Inc.
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
About MCBS MetroCity Bankshares Inc.
MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.